Prognostic significance of serum neuron-specific enolase in small cell carcinoma of the urinary bladder.

Abstract

PURPOSE:

Small cell carcinoma of the urinary bladder (SCCB) is known for its aggressive clinical features and poor prognosis. No prognostic factor has been established so far. The aim of this study was to assess the significance of possible prognostic factors, including serum neuron-specific enolase (NSE), an established biomarker for small cell lung carcinoma.

METHODS:

We retrospectively reviewed 31 patients with primary SCCB treated at our eight affiliate institutions between 2001 and 2014. The association of various clinicopathological factors at diagnosis, including the serum NSE value, with cancer-specific survival (CSS) was assessed. The log-rank test and Cox proportional hazards model were used for univariate and multivariate analyses, respectively.

RESULTS:

Nineteen (61.3 %) died of SCCB during the follow-up, with a median survival time of 12.7 months. Prognostic factors were analyzed for the 25 patients after excluding six with missing data. Univariate analysis demonstrated that stage (extensive disease) and serum NSE ≥25 ng/ml were significantly associated with worse CSS. Multivariate analysis identified increased serum NSE value as a sole independent predictor of CSS (hazard ratio 18.52, p = 0.0022).

CONCLUSIONS:

Serum NSE value at diagnosis was an independent prognostic factor for primary SCCB and may serve as a useful biomarker in the management of SCCB.

• Authors: Akihiro Naito, Satoru Taguchi, Tohru Nakagawa, Akihiko Matsumoto, Yasushi Nagase, Mariko Tabata, Jimpei Miyakawa, Motofumi Suzuki, Hiroaki Nishimatsu, Yutaka Enomoto, Shintaro Takahashi, Toshikazu Okaneya, Daisuke Yamada, Takamitsu Tachikawa, Shigeru Minowada, Tetsuya Fujimura, Hiroshi Fukuhara, Haruki Kume, Yukio Homma
• Journal: World journal of urology (World J Urol) Vol. 35 Issue 1 Pg. 97-103 (Jan 2017) ISSN: 1433-8726 [Electronic] Germany
• PMID: 27180266 (Publication Type: Journal Article)

Chemical References

• Biomarkers, Tumor
• Phosphopyruvate Hydratase

Topics

• Aged
• Biomarkers, Tumor (metabolism)
• Carcinoma, Small Cell (metabolism, mortality, pathology)
• Female
• Humans
• Male
• Middle Aged
• Multivariate Analysis
• Neoplasm Staging
• Phosphopyruvate Hydratase (metabolism)
• Prognosis
• Proportional Hazards Models
• Retrospective Studies
• Urinary Bladder Neoplasms (metabolism, mortality, pathology)